Bio-Techne And Regulus Therapeutics Announced Continued Technical And Clinical Collaboration Following Regulus' Topline Results From The Second Cohort Of Phase 1B Multiple Ascending Study Of RGLS8429 For Autosomal Dominant Polycystic Kidney Disease
Bio-Techne And Regulus Therapeutics Announced Continued Technical And Clinical Collaboration Following Regulus' Topline Results From The Second Cohort Of Phase 1B Multiple Ascending Study Of RGLS8429 For Autosomal Dominant Polycystic Kidney Disease
Bio-Techne 和 Regulus Therapeutics 宣布继续开展技术和临床合作，此前 Regulus 对常染色体显性遗传性多囊肾病的 RGLS8429 进行了第二组 1B 期多重上升研究的头条结果
Bio-Techne And Regulus Therapeutics Announced Continued Technical And Clinical Collaboration Following Regulus' Topline Results From The Second Cohort Of Phase 1B Multiple Ascending Study Of RGLS8429 For Autosomal Dominant Polycystic Kidney Disease
Bio-Techne 和 Regulus Therapeutics 宣布继续开展技术和临床合作，此前 Regulus 对常染色体显性遗传性多囊肾病的 RGLS8429 进行了第二组 1B 期多重上升研究的头条结果
译文内容由第三方软件翻译。
以上内容仅用作资讯或教育之目的，不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。